| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $384.0M | +1.6% | +1.4% |
| Cost of Revenue | $161.6M | +18.0% | +18.3% |
| Gross Profit | $222.4M | -7.7% | -8.2% |
| R&D Expense | $48.0M | +5.6% | +98.9% |
| SG&A Expense | $81.9M | +23.1% | +102.1% |
| Operating Income | $43.6M | -50.4% | -67.4% |
| Pre-tax Income | $42.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $382.0M | -45.1% | -55.9% |
| Accounts Receivable | $351.4M | +4.4% | +6.7% |
| Inventory | $62.0M | -0.2% | -12.4% |
| Current Assets | $925.1M | -23.0% | -28.6% |
| Total Assets | $2.28B | +7.6% | +11.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $300.0M | — | — |
| Capital Expenditures | $27.3M | — | — |
| Investing Cash Flow | -$615.7M | — | — |
| Financing Cash Flow | -$215.8M | — | — |
| Free Cash Flow | $272.7M | — | — |
| -59.5% |
| -75.9% |
| Income Tax | $14.6M | -43.3% | -67.6% |
| Net Income | $27.8M | -64.7% | -78.8% |
| EPS (Basic) | $0.41 | -64.3% | -78.3% |
| EPS (Diluted) | $0.41 | -63.4% | -77.1% |
| $346.8M |
| +23.8% |
| -55.8% |
| Long-term Debt | $567.9M | +0.2% | — |
| Total Liabilities | $1.16B | +21.9% | +33.0% |
| Stockholders' Equity | $1.12B | -4.1% | -5.1% |